Published in Mov Disord on October 15, 2007
Prospective study of statin use and risk of Parkinson disease. Arch Neurol (2012) 1.76
Statin use and the risk of Parkinson disease. Neurology (2008) 1.10
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of central nervous system diseases. Arch Neurol (2010) 1.08
Statin use and Parkinson's disease in Denmark. Mov Disord (2010) 0.93
Statin use and risk of Parkinson's disease: a meta-analysis of observational studies. J Neurol (2012) 0.88
Statin Use and the Risk of Parkinson's Disease: An Updated Meta-Analysis. PLoS One (2016) 0.80
Statin adherence and the risk of Parkinson's disease: A population-based cohort study. PLoS One (2017) 0.75
Circulating Cholesterol Levels May Link to the Factors Influencing Parkinson's Risk. Front Neurol (2017) 0.75
Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease. Mov Disord (2007) 2.24
Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med (2003) 10.61
Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Incidental findings on brain MRI in the general population. N Engl J Med (2007) 8.59
Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation (2006) 8.18
Epidemiology of Parkinson's disease. Lancet Neurol (2006) 8.13
Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA (2004) 6.06
The Rotterdam Study: objectives and design update. Eur J Epidemiol (2007) 5.78
Alcohol consumption and risk of dementia: the Rotterdam Study. Lancet (2002) 5.32
Genomewide association studies of stroke. N Engl J Med (2009) 5.29
Physical activity, including walking, and cognitive function in older women. JAMA (2004) 4.90
Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke (2003) 4.78
Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study. Lancet Neurol (2006) 4.77
Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet (2009) 4.56
Dietary intake of antioxidants and risk of Alzheimer disease. JAMA (2002) 4.01
Genome-wide association study of PR interval. Nat Genet (2010) 3.73
The Rotterdam Study: 2010 objectives and design update. Eur J Epidemiol (2009) 3.44
Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Arch Neurol (2004) 3.38
Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain (2005) 3.34
Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med (2004) 3.32
Incidence and prognosis of transient neurological attacks. JAMA (2007) 3.21
Measuring cognitive function with age: the influence of selection by health and survival. Epidemiology (2008) 3.19
Retinal vessel diameters and risk of hypertension: the Rotterdam Study. Hypertension (2005) 3.17
Cerebral white matter lesions and the risk of dementia. Arch Neurol (2004) 3.17
Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke (2002) 3.00
Atherosclerosis and risk for dementia. Ann Neurol (2007) 2.97
Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study. Circulation (2007) 2.82
Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol (2005) 2.80
Kidney function is related to cerebral small vessel disease. Stroke (2007) 2.77
High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study. Circulation (2006) 2.69
Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study. Arch Neurol (2009) 2.67
Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke (2006) 2.63
Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders? The Rotterdam Study. Invest Ophthalmol Vis Sci (2004) 2.53
Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study. Circulation (2005) 2.48
Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study. Stroke (2008) 2.48
Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc (2013) 2.47
Serum uric acid levels and the risk of Parkinson disease. Ann Neurol (2005) 2.47
Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol (2011) 2.37
Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat Genet (2010) 2.35
Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study. Ann Neurol (2002) 2.30
Prestroke cognitive performance, incident stroke, and risk of dementia: the Rotterdam Study. Stroke (2007) 2.27
Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol (2002) 2.27
Plasma clusterin and the risk of Alzheimer disease. JAMA (2011) 2.19
Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke (2003) 2.10
Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study. Stroke (2010) 2.04
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology (2011) 2.01
Arterial stiffness and cerebral small vessel disease: the Rotterdam Scan Study. Stroke (2012) 1.99
Interaction between hypertension, apoE, and cerebral white matter lesions. Stroke (2004) 1.93
Systemic markers of inflammation and cognitive decline in old age. J Am Geriatr Soc (2007) 1.91
Independent susceptibility markers for atrial fibrillation on chromosome 4q25. Circulation (2010) 1.90
Susceptibility loci for intracranial aneurysm in European and Japanese populations. Nat Genet (2008) 1.90
Vitamin B12, folate, and homocysteine in depression: the Rotterdam Study. Am J Psychiatry (2002) 1.88
Genome-wide association study of intracranial aneurysm identifies three new risk loci. Nat Genet (2010) 1.86
Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people. Arch Gen Psychiatry (2006) 1.85
Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nat Genet (2012) 1.79
Antipsychotics and the risk of sudden cardiac death. Arch Intern Med (2004) 1.78
White matter microstructural integrity and cognitive function in a general elderly population. Arch Gen Psychiatry (2009) 1.74
Incidence of cerebral microbleeds in the general population: the Rotterdam Scan Study. Stroke (2011) 1.70
Hippocampus segmentation in MR images using atlas registration, voxel classification, and graph cuts. Neuroimage (2008) 1.69
PARK6-linked parkinsonism occurs in several European families. Ann Neurol (2002) 1.68
Serum calcium and cognitive function in old age. J Am Geriatr Soc (2007) 1.66
Stroke is associated with coronary calcification as detected by electron-beam CT: the Rotterdam Coronary Calcification Study. Stroke (2002) 1.66
High von Willebrand factor levels increase the risk of stroke: the Rotterdam study. Stroke (2010) 1.64
Methylenetetrahydrofolate reductase C677T genotype and PD. Ann Neurol (2005) 1.64
Lobar distribution of cerebral microbleeds: the Rotterdam Scan Study. Arch Neurol (2011) 1.62
Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis. Am J Epidemiol (2009) 1.60
The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study. Hypertension (2004) 1.59
Inflammatory proteins and depression in the elderly. Epidemiology (2003) 1.58
Retinal vessel diameters and cerebral small vessel disease: the Rotterdam Scan Study. Brain (2005) 1.57
Four novel Loci (19q13, 6q24, 12q24, and 5q14) influence the microcirculation in vivo. PLoS Genet (2010) 1.57
Meta-analysis: retinal vessel caliber and risk for coronary heart disease. Ann Intern Med (2009) 1.54
Genome-wide joint meta-analysis of SNP and SNP-by-smoking interaction identifies novel loci for pulmonary function. PLoS Genet (2012) 1.52
Common variants at 6q22 and 17q21 are associated with intracranial volume. Nat Genet (2012) 1.51
A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline. Brain (2010) 1.49
Serum cholesterol levels and the risk of Parkinson's disease. Am J Epidemiol (2006) 1.49
Decreased glomerular filtration rate is a risk factor for hemorrhagic but not for ischemic stroke: the Rotterdam Study. Stroke (2007) 1.47
Genome-wide association studies of MRI-defined brain infarcts: meta-analysis from the CHARGE Consortium. Stroke (2009) 1.47
Variation in the estrogen receptor alpha gene and risk of stroke: the Rotterdam Study. Stroke (2008) 1.45
Accuracy and reproducibility study of automatic MRI brain tissue segmentation methods. Neuroimage (2010) 1.44
Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study. Am J Clin Nutr (2003) 1.43
Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. J Clin Oncol (2012) 1.43
Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia. Stroke (2005) 1.42
Paroxysmal disorders in infancy and their risk factors in a population-based cohort: the Generation R Study. Dev Med Child Neurol (2010) 1.40
Identification of a common variant at the NOS1AP locus strongly associated to QT-interval duration. Hum Mol Genet (2008) 1.37
Relationship between atherosclerosis and late-life depression: the Rotterdam Study. Arch Gen Psychiatry (2004) 1.36
Prognosis of Parkinson disease: risk of dementia and mortality: the Rotterdam Study. Arch Neurol (2005) 1.34
Lipoprotein-associated phospholipase A2 and measures of extracoronary atherosclerosis: the Rotterdam Study. Arterioscler Thromb Vasc Biol (2005) 1.32
Association between blood pressure levels over time and brain atrophy in the elderly. Neurobiol Aging (2002) 1.32
Brain tissue volumes in the general elderly population. The Rotterdam Scan Study. Neurobiol Aging (2007) 1.31
Brain tissue volumes and small vessel disease in relation to the risk of mortality. Neurobiol Aging (2007) 1.30
Serum uric acid and cognitive function and dementia. Brain (2008) 1.30
Arterial stiffness, cognitive decline, and risk of dementia: the Rotterdam study. Stroke (2007) 1.30
Subjective memory complaints, education, and risk of Alzheimer's disease. Alzheimers Dement (2007) 1.29
Cerebral microbleeds: accelerated 3D T2*-weighted GRE MR imaging versus conventional 2D T2*-weighted GRE MR imaging for detection. Radiology (2008) 1.24
Genetic variation in NOS1AP is associated with sudden cardiac death: evidence from the Rotterdam Study. Hum Mol Genet (2009) 1.23
Dietary intakes of berries and flavonoids in relation to cognitive decline. Ann Neurol (2012) 1.23
Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. Arch Gen Psychiatry (2012) 1.21
A prospective analysis of elevated fasting glucose levels and cognitive function in older people: results from PROSPER and the Rotterdam Study. Diabetes (2010) 1.17
Alzheimer's disease genes and cognition in the nondemented general population. Biol Psychiatry (2012) 1.17